WebFeb 19, 2024 · Hangzhou Sciwind Biosciences Co., Ltd., a Hangzhou, China-based clinical-stage biopharmaceutical company focusing on research and development of innovative biologics, closed a US$37M series B... WebSciwind Total Funding $66.5 M Company summary Overview Sciwind (先为达是) is a biotech company that focuses on metabolic diseases, especially fibrotic diseases. It aims …
Did you know?
WebSep 27, 2024 · SAN FRANCISCO, Calif. and HANGZHOU, China, Sept. 26, 2024 /PRNewswire/ -- Sciwind Biosciences, a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies ... WebNov 30, 2024 · HANGZHOU, China and SAN FRANCISCO, Nov. 30, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on …
WebFeb 19, 2024 · Hangzhou Sciwind Biosciences Co., Ltd., a Hangzhou, China-based clinical-stage biopharmaceutical company focusing on research and development of … WebJul 12, 2024 · Sciwind Biosciences is a cross-border biopharmaceutical company focusing on discovering and developing innovative therapies to treat chronic, metabolic and …
http://sciwind.com.cn/ WebOct 10, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 10, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative ...
WebOct 12, 2024 · HANGZHOU, China and SAN FRANCISCO, Oct. 12, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative therapies to treat metabolic disease, today announced the closing of an $70 million Series C financing.
WebAddress: Room 1802, Building 2, Hangzhou Dongbu International Business Center, Qiantang District Development Zone Hangzhou, Zhejiang, 310000 China See other … st katherine\u0027s school abingdonWebAug 8, 2024 · HANGZHOU, China and SAN FRANCISCO, Aug. 8, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced positive interim topline results from a 26-week Phase 1c/2a clinical trial of … st katherine\u0027s schoolWebApr 14, 2024 · HANGZHOU, China and SAN FRANCISCO, April 13, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative ... st katherine\u0027s school \u0026 nurseryWebJun 9, 2024 · HANGZHOU, China and SAN FRANCISCO, June 8, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focusing on discovering and developing innovative... st katherine\u0027s greek festivalWebWe are a fast-growing clinical-stage biopharmaceutical company developing a portfolio of therapeutic candidates for metabolic disease. Our goal is to develop first-in-class and … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, CA 94583, USA. … XW004 is an oral formulation of the GLP-1 peptide analog XW003. To enable oral … Sciwind Biosciences is a fast-growing clinical-stage biopharmaceutical … Prior to founding Sciwind Biosciences, Dr. Pan held leadership roles at Amgen, as … Sciwind Biosciences Announces Positive Topline Results from 20-week Phase 2 … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, California 94583, … USA Headquarters. 3001 Bishop Drive, Suite 300 San Ramon, California 94583, … st katherine\u0027s school bournemouthWebDec 9, 2024 · February 18, 2024 Sciwind Biosciences Secures US$37 Million Series B Financing Partnerships At Sciwind, we are interested in collaborators who share our vision and goals, and whose capabilities … st katherine\u0027s school bristolWebJan 18, 2024 · HANGZHOU, China and SAN FRANCISCO, Jan. 17, 2024 /PRNewswire/ -- Sciwind Biosciences Co., Ltd., a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies to treat metabolic disease, today announced the initiation of patient dosing in its Phase 2b clinical trial of XW003 in … st katherine\u0027s school pill bristol